Why insider trading matters?

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

- Peter Lynch
MACROGENICS INC (MGNX)
Sector: Healthcare; Industry: Biotechnology

MacroGenics, Inc., a biopharmaceutical company, discovers and develops antibody-based therapeutics for the treatment of cancer in the United States. In addition, the company is developing combination of MGD009 and MGA012; MGC018, an antibody drug conjugate, which targets solid tumors expressing B7-H3; and MGD014, a DART molecule that targets envelope protein of human immunodeficiency virus infected cells and T cells. It has strategic collaborations with Incyte Corporation; Zai Lab Limited; and I-Mab Biopharma.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-06-16 BIOTECH TARGET N V 10%-Owner Buy 175,000 $20.82 $3,644,005 No
2021-03-22 Bonvini Ezio Sr VP, Research & CSO Sell 3,917 $32.00 $125,344 No
2020-12-29 Risser Eric Blasius Sr VP & Chief Business Officer Sell 500 $24.10 $12,050 Yes
2020-11-30 Risser Eric Blasius Sr VP & Chief Business Officer Sell 500 $23.35 $11,675 Yes
2020-10-28 Risser Eric Blasius Sr VP & Chief Business Officer Sell 1,500 $20.69 $31,035 Yes
2020-09-28 Risser Eric Blasius Sr VP & Chief Business Officer Sell 500 $25.33 $12,665 Yes
2020-09-18 Bonvini Ezio Sr VP, Research & CSO Sell 62,851 $30.50 $1,916,867 No
2020-09-09 Galbraith Kenneth Director Sell 20,773 $27.11 $563,156 Yes
2020-08-26 Risser Eric Blasius Sr VP & Chief Business Officer Sell 500 $27.10 $13,550 Yes
2020-08-20 Spitznagel Thomas Sr VP, BPD & Manufacturing Sell 7,500 $26.87 $201,525 Yes
2020-07-27 Risser Eric Blasius Sr VP & Chief Business Officer Sell 4,489 $25.47 $114,319 Yes
2020-05-26 Risser Eric Blasius Sr VP & Chief Business Officer Sell 500 $26.59 $13,295 Yes
2020-02-20 Risser Eric Blasius Sr VP & Chief Business Officer Sell 500 $10.84 $5,420 Yes
2019-02-06 Peters Jeffrey Stuart General Counsel Sell 68 $30.00 $2,040 No
2018-01-24 Risser Eric Blasius Sr VP & Chief Business Officer Sell 3,000 $22.50 $67,500 Yes
2018-01-24 Risser Eric Blasius Sr VP & Chief Business Officer Sell 3,000 $22.50 $67,500 Yes
2018-01-17 Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Sell 5,000 $20.00 $100,000 Yes
2017-06-05 Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Sell 5,000 $20.00 $100,000 Yes
2016-10-03 Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Sell 10,000 $29.34 $293,400 Yes
2016-07-01 Wigginton Jon Marc Sr VP Clinical Dev & CMO Sell 5,000 $27.22 $136,100 Yes
2016-07-01 Cilinski Lynn VP, Controller and Treasurer Sell 8,922 $27.22 $242,857 Yes
2016-05-27 Cilinski Lynn VP, Controller and Treasurer Sell 5,000 $25.00 $125,000 Yes
2016-03-03 Costa Paulo F Director Buy 10,000 $17.20 $172,000 No
2016-01-04 Wigginton Jon Marc Sr VP, Clinical Sell 10,000 $29.64 $296,400 Yes
2015-11-23 Cilinski Lynn VP, Controller and Treasurer Sell 6,921 $35.00 $242,235 Yes
2015-10-15 Bonvini Ezio Senior VP, Research Sell 6,233 $25.21 $157,134 No
2015-10-01 Wigginton Jon Marc Sr VP, Clinical Sell 5,000 $21.11 $105,550 Yes
2015-07-10 Bonvini Ezio Senior VP, Research Sell 2,400 $38.09 $91,416 Yes
2015-06-24 Bonvini Ezio Senior VP, Research Sell 6,097 $38.08 $232,174 Yes
2015-06-15 Bonvini Ezio Senior VP, Research Sell 6,233 $34.01 $211,984 Yes

Insider Smart

Enphase Energy, Inc (ENPH) - Watch for CEO Kothandaraman Badrinarayanan and CFO Branderiz Eric, their trading have a good pattern you can't miss, very well timed buy low and sell high.

Insider Smart

Edesa Biotech, Inc. (EDSA) - President and CEO bought shares of EDSA in late May around $3, two weeks after their purchase, the stock jump to $9, very well timed buy.